Santra Archismita, Sharma K Aparna, Singh Neha, Yadav Kapil, Kant Shashi
Community Medicine, All India Institute of Medical Sciences, Raipur, Raipur, IND.
Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
Cureus. 2023 Feb 25;15(2):e35472. doi: 10.7759/cureus.35472. eCollection 2023 Feb.
Severe anemia is a high-risk factor in pregnancy and needs to be treated appropriately to prevent poor maternal and fetal outcomes. A pregnant woman with severe anemia reluctant for blood transfusion due to issues of accessibility was given four doses of 300 mg intravenous iron sucrose (IVIS) in 300 ml normal saline starting at 31 weeks 5 days of gestation and her hemoglobin level increased by 4.2 gm/dl over a period of five weeks without any complications and without any intake of iron and folic acid tablets during the entire duration. Intravenous iron sucrose is a useful intervention for severe anemia of pregnancy even in late pregnancy with rapid increase in haemoglobin levels and can be used regularly for treating severe anemia in pregnant women alternative to blood transfusion who have limited accessibility to blood transfusion facilities.
重度贫血是妊娠的高危因素,需要进行适当治疗以预防母婴不良结局。一名因获取血液困难而不愿输血的重度贫血孕妇,在妊娠31周5天时开始,在300毫升生理盐水中静脉注射四剂300毫克蔗糖铁(IVIS),其血红蛋白水平在五周内升高了4.2克/分升,无任何并发症,且在整个期间未服用任何铁剂和叶酸片。静脉注射蔗糖铁是治疗妊娠重度贫血的有效干预措施,即使在妊娠晚期也能使血红蛋白水平快速升高,对于那些获取输血设施受限、可替代输血治疗重度贫血的孕妇可常规使用。